Canadian Institute’s Pathways to Access and Reimbursement conference

Partner Eileen McMahon will speak at the Canadian Institute’s Pathways to Access and Reimbursement conference taking place on January 20-21. This year’s conference will cover a range of topics, including discussion on how to attract and retain talent to Canada’s life sciences sector, the impact of the pandemic on CADTH reviews and pCPA negotiations, and how to obtain, analyze, and apply health outcome data to empower decision-making from clinical trials to reimbursement.

Eileen will speak on the “PMPRB Implications and Takeaways for Companies” at 3:30 p.m. on January 20, where her and fellow panelists will provide an overview on the proposed changes affecting patented medicines and how will they impact businesses, the uncertainties and predictions as to where the PMPRB changes will end up, and more.

You can find out more about the conference on the Canadian Institute’s website.